Intended for healthcare professionals


Interferon treatment is beneficial in early multiple sclerosis

BMJ 2000; 321 doi: (Published 07 October 2000) Cite this as: BMJ 2000;321:851
  1. Fred Charatan
  1. Florida

    Treatment with interferon beta-1a (Avonex) reduced the rate of development of multiple sclerosis in patients with early signs of the disease by about a half, a study in the New England Journal of Medicine has shown (NEJM 2000;343:898-904).

    The study was carried out at 50 US and Canadian hospitals on 383 patients, each of whom had at least one episode of neurological symptoms indicating …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription